Standard Operating Procedure for Manufacturing of Thermosensitive Gels in Gel Production

1. Purpose

To provide a standardized procedure for the formulation and manufacturing of thermosensitive gels that transition in viscosity or state in response to temperature changes, ensuring product quality and consistency.

2. Scope

This SOP applies to the manufacturing process of all thermosensitive gel formulations produced in the Gel Manufacturing department.

3. Responsibilities

• Production Chemist: Execute the gel manufacturing process as per approved batch manufacturing record (BMR).
• Quality Assurance: Monitor in-process checks and approve intermediate and final products.
• R&D/Technology Transfer: Provide formulation details, critical temperature control points, and transition behavior validation data.

4. Accountability

The Head – Manufacturing is accountable for ensuring strict compliance to this SOP.

5. Procedure

5.1 Material Preparation and Verification

1. Collect and verify raw materials as per the BMR and approved bill of materials.
2. Ensure all thermosensitive agents (e.g., poloxamers, methylcellulose) are handled at controlled temperatures.
3. Confirm the presence of specific thermal transition temperatures and material compatibility.

5.2 Equipment Preparation

1. Use jacketed mixing vessels with integrated temperature sensors and chillers.
2. Calibrate temperature probes and ensure uniform cooling/heating across the vessel.
3. Perform cleaning and line clearance as per the equipment logbook and cleaning SOPs.

5.3 Gel Preparation Process

1. Charge purified water into the vessel at the pre-determined temperature (usually 4–10°C).
2. Add excipients and stir gently using slow agitation to prevent air entrapment.
3. Gradually add thermosensitive agents (e.g., Poloxamer 407) under continuous stirring until fully hydrated.
4. Allow swelling for the defined duration (often overnight at refrigerated conditions).

5.4 Drug Incorporation and Homogenization

1. Warm the mixture to the predefined transition temperature (typically 20–30°C) to achieve sol-to-gel transformation behavior.
2. Disperse or dissolve the active pharmaceutical ingredient (API) under continuous stirring until uniform.
3. Use a homogenizer to achieve a consistent gel texture without disrupting the temperature-sensitive properties.

5.5 pH Adjustment and Final Processing

1. Measure the pH and adjust if necessary using pre-approved acid or base (e.g., citric acid, sodium hydroxide).
2. Pass the gel through a filtration system if required (based on product specification).
3. Conduct viscosity and temperature shift behavior tests before approving the batch for filling.

5.6 Filling and Packaging

1. Transfer the gel under a nitrogen blanket (if applicable) to avoid oxidation.
2. Fill into containers using thermostatically controlled nozzles to prevent premature gelling.
3. Seal and label as per batch packaging record (BPR) and transfer for final QC testing.

5.7 Documentation and Cleaning

1. Record all manufacturing parameters in the batch manufacturing record.
2. Clean all equipment as per the validated cleaning procedure for thermosensitive products.
3. Submit samples to Quality Control for release testing.

6. Abbreviations

• SOP: Standard Operating Procedure
• BMR: Batch Manufacturing Record
• BPR: Batch Packaging Record
• API: Active Pharmaceutical Ingredient

7. Documents

1. Batch Manufacturing Record – Annexure-1
2. Temperature Monitoring Log – Annexure-2
3. Transition Temperature Verification Sheet – Annexure-3
4. Equipment Calibration Certificate – Annexure-4
5. Homogenization Verification Log – Annexure-5

8. References

• ICH Q8: Pharmaceutical Development
• WHO GMP Guidelines – Annex 2: Manufacturing of Semi-Solid Dosage Forms
• USP General Chapter <795> – Pharmaceutical Compounding

9. SOP Version

Version: 2.0

10. Approval Section

11. Annexures

Annexure-1: Batch Manufacturing Record

Annexure-2: Temperature Monitoring Log

Annexure-3: Transition Temperature Verification Sheet

Annexure-4: Equipment Calibration Certificate

Annexure-5: Homogenization Verification Log

Revision History

Standard Operating Procedure for Monitoring Cross-Contamination in Gel Manufacturing

1. Purpose

To define the procedure for monitoring and preventing cross-contamination in gel manufacturing operations, ensuring the integrity and safety of products.

2. Scope

This SOP applies to all gel manufacturing areas, including material handling, processing, equipment usage, and personnel movement within the facility.

3. Responsibilities

• QA Department: Monitor compliance, review reports, and investigate any deviations.
• Production Department: Implement preventive measures and ensure adherence to the procedure.
• Engineering Department: Ensure facility design and HVAC systems support contamination control.

4. Accountability

The Head – Quality Assurance is accountable for ensuring effective implementation of this SOP.

5. Procedure

5.1 Identification of Cross-Contamination Risks

1. Perform risk assessments for all manufacturing activities including equipment sharing, cleaning practices, and personnel flow.
2. Identify potential sources: raw materials, intermediates, product residues, environmental contaminants, and cleaning agents.

5.2 Preventive Measures

1. Ensure dedicated equipment or perform validated cleaning between product batches.
2. Use color-coded tools and accessories for different production stages or products.
3. Maintain physical segregation or use validated cleaning methods if equipment is shared.
4. Implement airlocks and pressure differentials to control airborne contamination.

5.3 Monitoring Mechanism

1. Routine environmental monitoring through settle plates, swabs, and air samplers.
2. Visual inspections during and after cleaning.
3. Verification of cleaning effectiveness using swab tests and rinse samples.
4. Batch-to-batch cross-contamination checks through analytical testing of swabs/rinse.

5.4 Documentation and Reporting

1. Record all monitoring data in the Cross-Contamination Monitoring Log (Annexure-1).
2. Document inspection findings, deviations, and corrective actions in relevant formats (Annexure-2 and 3).

5.5 Training and Awareness

1. Conduct periodic training for personnel on contamination risks and control practices.
2. Use case studies and past incidents as training material to improve awareness.

5.6 Investigations and Corrective Actions

1. Initiate deviation report if any instance of cross-contamination is suspected or detected.
2. Conduct root cause analysis and implement CAPA (Corrective and Preventive Action).
3. Review process design or layout if recurring contamination is observed.

6. Abbreviations

• CAPA: Corrective and Preventive Action
• QA: Quality Assurance
• SOP: Standard Operating Procedure

7. Documents

1. Cross-Contamination Monitoring Log – Annexure-1
2. Cleaning Verification Checklist – Annexure-2
3. Cross-Contamination Deviation Form – Annexure-3
4. Training Attendance Sheet – Annexure-4
5. CAPA Implementation Record – Annexure-5

8. References

• WHO TRS 986 Annex 2: GMP for Pharmaceutical Products
• EU GMP Guidelines – Chapter 5: Production
• ICH Q9: Quality Risk Management

9. SOP Version

Version: 2.0

10. Approval Section

11. Annexures

Annexure-1: Cross-Contamination Monitoring Log

Annexure-2: Cleaning Verification Checklist

Annexure-3: Cross-Contamination Deviation Form

Annexure-4: Training Attendance Sheet

Annexure-5: CAPA Implementation Record

Revision History

Standard Operating Procedure for Environmental Monitoring in Gel Production Areas

1. Purpose

To lay down the procedure for systematic environmental monitoring in gel manufacturing areas to ensure control of microbial and particulate contamination.

2. Scope

This procedure applies to all controlled areas of the gel manufacturing facility including dispensing, mixing, filling, and packing areas.

3. Responsibilities

• QA Officer: To perform environmental monitoring and record data.
• Microbiologist: To analyze samples and report results.
• Production Supervisor: To ensure readiness and compliance of the area prior to monitoring.

4. Accountability

Head – Quality Assurance is accountable for implementation and compliance with this SOP.

5. Procedure

5.1 Types of Monitoring

1. Airborne Particulate Monitoring: Using particle counter to assess viable and non-viable particles.
2. Settle Plates: Petri dishes placed at key locations to collect settling microorganisms.
3. Surface Monitoring: Swabbing of equipment, walls, and floors.
4. Personnel Monitoring: Contact plates on gloves and gowns.

5.2 Frequency

1. Daily for Grade A areas.
2. Weekly for Grade B areas.
3. Monthly for Grade C and D areas.

5.3 Sampling Procedure

1. Ensure that equipment like particle counters and air samplers are calibrated and clean.
2. Label sampling points clearly as per the Environmental Monitoring Map (Annexure-1).
3. Use sterile swabs, settle plates, and contact plates for microbial sampling.
4. Follow unidirectional flow and avoid disturbances during sampling.

5.4 Limits and Actions

1. Follow defined alert and action limits as per WHO and GMP guidelines.
2. Any result beyond action limits must trigger a deviation report and investigation.
3. Repeated out-of-specification results must lead to area qualification or re-cleaning.

5.5 Data Recording and Trending

1. Record all data in the Environmental Monitoring Log (Annexure-2).
2. Review monthly trends to detect patterns or potential risks (Annexure-3).
3. QA to prepare quarterly reports for internal audit and management review.

5.6 Storage and Disposal

1. After incubation, plates must be documented and disposed of in biohazard waste containers.
2. Plates showing growth must be labeled and sent for microbial identification.

6. Abbreviations

• CFU: Colony Forming Units
• EM: Environmental Monitoring
• QA: Quality Assurance
• GMP: Good Manufacturing Practices

7. Documents

1. Environmental Monitoring Map – Annexure-1
2. EM Log Sheet – Annexure-2
3. Monthly Trend Analysis Sheet – Annexure-3
4. Deviation Report Template – Annexure-4
5. Microbial Identification Record – Annexure-5

8. References

• WHO TRS 961 Annex 6 – GMP for Sterile Pharmaceutical Products
• EU GMP Annex 1 – Manufacture of Sterile Medicinal Products
• ISPE Baseline Guide – Cleanroom Design

9. SOP Version

Version: 2.0

10. Approval Section

11. Annexures

Annexure-1: Environmental Monitoring Map

Layout map indicating designated EM points with reference numbers.

Annexure-2: Environmental Monitoring Log

Annexure-3: Monthly Trend Analysis Sheet

Annexure-4: Deviation Report Template

Annexure-5: Microbial Identification Record

Revision History

Standard Operating Procedure for Cosmetic GMP Compliance in Gel Manufacturing

1. Purpose

To define the procedure for ensuring compliance with Cosmetic Good Manufacturing Practice (GMP) guidelines as per BIS and ISO 22716 during the manufacturing of cosmetic gels.

2. Scope

This SOP applies to the entire process of cosmetic gel manufacturing including material handling, production, quality control, packaging, storage, and documentation.

3. Responsibilities

• Production Officer: Ensure all activities are carried out as per this SOP.
• QA Department: Responsible for auditing and verifying compliance.
• Warehouse Personnel: Ensure proper storage and traceability of materials.

4. Accountability

Head – Manufacturing is accountable for implementing this SOP in compliance with cosmetic GMP regulations.

5. Procedure

5.1 Personnel and Hygiene Requirements

1. All personnel involved in the process must be trained in cosmetic GMP.
2. Personal hygiene standards including protective clothing, gloves, and hairnets must be maintained.
3. Health status of employees should be monitored and documented.

5.2 Facility and Equipment Controls

1. Manufacturing areas must be segregated and cleaned as per cleaning SOP/GM/072/2025.
2. Ensure maintenance and calibration of equipment used in gel manufacturing.
3. Environmental controls must include temperature, humidity, and air quality checks.

5.3 Raw Material Handling

1. Only approved cosmetic-grade raw materials shall be used.
2. All materials must be stored under labeled conditions in designated areas.
3. Maintain traceability through batch records and purchase documentation.

5.4 Manufacturing Controls

1. Follow defined process parameters (e.g., mixing time, temperature) for each gel batch.
2. Document each step in the Batch Manufacturing Record (BMR).
3. Apply in-process checks such as viscosity, appearance, and odor at designated intervals.

5.5 Packaging and Labeling

1. Use pre-approved packaging materials conforming to cosmetic standards.
2. Ensure correct labeling including batch number, Mfg/Exp date, usage instructions, and warnings.
3. Perform label reconciliation and documentation after each batch.

5.6 Quality Control and Release

1. Perform final testing for pH, microbial count, physical appearance, and heavy metals as applicable.
2. Maintain Certificate of Analysis (CoA) for each batch.
3. Only QA-approved batches shall be released for distribution.

5.7 Documentation and Record Keeping

1. Maintain all records for at least 3 years from date of manufacture.
2. Ensure records are legible, dated, and signed by authorized personnel.
3. Records include BMR, cleaning logs, calibration reports, and training files.

6. Abbreviations

• GMP: Good Manufacturing Practice
• BMR: Batch Manufacturing Record
• QA: Quality Assurance
• CoA: Certificate of Analysis

7. Documents

1. Batch Manufacturing Record – Annexure-1
2. Training Record Sheet – Annexure-2
3. Environmental Monitoring Log – Annexure-3
4. Label Reconciliation Sheet – Annexure-4
5. CoA Template for Cosmetic Gels – Annexure-5

8. References

• ISO 22716 – Guidelines on Good Manufacturing Practices for Cosmetic Products
• IS 4707 Part 2: List of raw materials generally not recognized as safe
• Schedule S – Drugs and Cosmetics Act, India

9. SOP Version

Version: 2.0

10. Approval Section

11. Annexures

Annexure-1: Batch Manufacturing Record

Annexure-2: Training Record Sheet

Annexure-3: Environmental Monitoring Log

Annexure-4: Label Reconciliation Sheet

Annexure-5: CoA Template for Cosmetic Gels

Revision History

Standard Operating Procedure for Manufacturing Thermosensitive Gels in Gel Manufacturing

1. Purpose

To outline the procedure for manufacturing thermosensitive gels that undergo sol-gel transformation in response to body or ambient temperature, ensuring product quality, consistency, and compliance.

2. Scope

This SOP is applicable to all thermosensitive gel formulations processed in the Gel Manufacturing Department of the pharmaceutical facility.

3. Responsibilities

• Formulation Scientist: Responsible for selection of thermosensitive polymers and formulation design.
• Production Chemist: Executes batch processing under controlled conditions.
• Quality Assurance (QA): Monitors compliance and reviews batch records.

4. Accountability

Head – Manufacturing is accountable for ensuring compliance with this SOP.

5. Procedure

5.1 Raw Material and Equipment Preparation

1. Verify availability of key ingredients such as Pluronic F127, Pluronic F68, or other approved thermoresponsive polymers.
2. Ensure all materials are approved and released by QA.
3. Calibrate temperature probes and ensure vessels are cleaned as per SOP/GM/073/2025.

5.2 Gel Compounding Process

1. Dissolve polymer base in cold purified water (2–8°C) using a mechanical stirrer.
2. Maintain continuous agitation while gradually increasing polymer concentration for required gelation temperature.
3. Incorporate drug substance at low temperature to prevent degradation.
4. pH and viscosity should be monitored and adjusted accordingly using buffer agents.

5.3 Sol-Gel Transition Verification

1. Transfer small quantity of gel to test vials and gradually heat to 37°C to assess sol-gel transition.
2. Document gelation point and confirm against the specification in Annexure-3.

5.4 Filling and Sealing

1. Filter final product through sterile mesh where applicable.
2. Fill into pre-cooled containers to preserve sol state at the time of filling.
3. Seal and label containers with batch details.

5.5 In-process Controls and QC Testing

• Appearance, sol-gel transition temperature, viscosity at room and body temperature, drug content, pH, and microbial limits.
• Perform in-vitro release studies at different temperatures to assess temperature sensitivity.

5.6 Documentation

1. Fill out batch manufacturing record and record all temperatures and times accurately.
2. Attach cleaning logs, calibration logs, and deviation reports if any.

6. Abbreviations

• QA: Quality Assurance
• QC: Quality Control
• BMR: Batch Manufacturing Record
• SOP: Standard Operating Procedure

7. Documents

1. Batch Manufacturing Record – Annexure-1
2. Thermosensitive Gel Formulation Sheet – Annexure-2
3. Sol-Gel Transition Test Report – Annexure-3
4. In-Process Control Checklist – Annexure-4
5. Filling and Sealing Log – Annexure-5

8. References

• ICH Q8: Pharmaceutical Development
• ICH Q6A: Specifications
• Schedule M – GMP Guidelines

9. SOP Version

Version: 2.0

10. Approval Section

11. Annexures

Annexure-1: Batch Manufacturing Record

Annexure-2: Thermosensitive Gel Formulation Sheet

Annexure-3: Sol-Gel Transition Test Report

Annexure-4: In-Process Control Checklist

Annexure-5: Filling and Sealing Log

Revision History

Standard Operating Procedure for Preparing Gels with pH-Sensitive Drug Release Mechanism

1. Purpose

To define the standardized procedure for manufacturing gels that incorporate pH-sensitive drug release technology, ensuring accuracy, reproducibility, and compliance with regulatory standards.

2. Scope

This SOP applies to the formulation, compounding, and filling of gels exhibiting pH-responsive drug release characteristics, specifically within the Gel Manufacturing Department.

3. Responsibilities

• Formulation Scientist: Designs the pH-responsive gel matrix and approves excipient compatibility.
• Production Chemist: Ensures strict adherence to process parameters and batch instructions.
• QA Executive: Verifies in-process controls and reviews batch records.

4. Accountability

Head – Manufacturing is accountable for the overall implementation, control, and review of the procedure.

5. Procedure

5.1 Material and Equipment Preparation

1. Review the batch manufacturing record (BMR) and pH-specific formulation protocol.
2. Verify availability and status of all raw materials including polymers like Carbopol, Eudragit, or HPMC derivatives.
3. Calibrate pH meters and check buffer solutions used in testing.
4. Clean and prepare mixing vessels, agitators, and filling machines as per SOP/GM/073/2025.

5.2 pH-Sensitive Matrix Formulation

1. Dissolve polymeric base in purified water under continuous stirring at controlled temperature.
2. Add pH-sensitive drug compound ensuring full dispersion; use a homogenizer if needed.
3. Adjust gel viscosity and transparency by titration with acid/base until optimal pH range is achieved (typically pH 5.5–6.8).
4. Perform in-process pH testing and record results (refer Annexure-2).

5.3 Drug Incorporation and Final Homogenization

1. Add active pharmaceutical ingredient (API) dissolved or suspended in pre-filtered vehicle.
2. Mix until uniform distribution is achieved and test for homogeneity (refer Annexure-3).
3. Add preservatives, stabilizers, or pH indicators if applicable.

5.4 Filling and Packaging

1. Filter gel through 80–120 mesh if required to ensure consistency.
2. Transfer into filling machine and fill into laminated or aluminum tubes under controlled conditions.
3. Seal, crimp, and print batch details. Samples for QC testing must be retained (see Annexure-4).

5.5 In-Process and QC Tests

• Appearance, pH, viscosity, drug content uniformity, microbial limits, and pH-triggered release profiling.
• Ensure pH-triggered release profile is verified through in-vitro dissolution studies.

5.6 Documentation

1. Complete batch manufacturing and control records.
2. Attach calibration certificates of pH meters and any deviation reports.

6. Abbreviations

• API: Active Pharmaceutical Ingredient
• BMR: Batch Manufacturing Record
• HPMC: Hydroxypropyl Methylcellulose
• QA: Quality Assurance

7. Documents

1. Batch Manufacturing Record – Annexure-1
2. pH Adjustment Log – Annexure-2
3. Homogeneity Test Record – Annexure-3
4. Filling Activity Log – Annexure-4
5. pH-Responsive Drug Release Profile – Annexure-5

8. References

• ICH Q8: Pharmaceutical Development
• ICH Q6A: Specifications – Test Procedures and Acceptance Criteria
• Schedule M: Good Manufacturing Practices

9. SOP Version

Version: 2.0

10. Approval Section

11. Annexures

Annexure-1: Batch Manufacturing Record

Annexure-2: pH Adjustment Log

Annexure-3: Homogeneity Test Record

Annexure-4: Filling Activity Log

Annexure-5: pH-Responsive Drug Release Profile

Revision History

Standard Operating Procedure for Monitoring Cross-Contamination in Gel Manufacturing

1. Purpose

To define the procedure for identifying, preventing, monitoring, and documenting cross-contamination events in gel manufacturing processes, in accordance with GMP and regulatory guidelines.

2. Scope

This SOP applies to all stages of gel manufacturing, including material handling, equipment usage, processing, in-process storage, and cleaning, at the Gel Manufacturing facility.

3. Responsibilities

• Production Chemist: Ensures compliance with prevention measures during manufacturing.
• QA Officer: Performs periodic monitoring and audits for potential contamination sources.
• Housekeeping Staff: Follows defined cleaning procedures between product batches.
• Engineering Department: Maintains air handling systems and equipment integrity.

4. Accountability

Head – Manufacturing is accountable for overall implementation of cross-contamination controls and ensuring compliance with the SOP.

5. Procedure

5.1 Identification of Cross-Contamination Risks

1. Review process flow diagrams for each gel product to identify potential contamination crossover points.
2. Classify risks based on type: airborne, mechanical, personnel-borne, or equipment-induced.

5.2 Preventive Controls

1. Implement physical segregation for materials and products with different actives.
2. Use dedicated equipment for highly sensitizing or potent APIs wherever applicable.
3. Establish unidirectional personnel and material flow.
4. Ensure use of color-coded tools, containers, and garments.
5. Maintain appropriate pressure differentials in processing rooms.

5.3 Environmental Monitoring

1. Perform regular air sampling and surface swabbing after each product batch.
2. Monitor microbial load and particulate matter in manufacturing and filling areas.
3. Maintain records as per Annexure-2 and Annexure-3.

5.4 Cleaning and Line Clearance

1. Follow validated cleaning procedures for all equipment and surfaces (Refer Annexure-4).
2. Conduct line clearance using approved checklists.
3. Record equipment cleaning in the Equipment Cleaning Record (Annexure-5).

5.5 Investigation of Cross-Contamination Events

1. Initiate deviation report for any suspected contamination.
2. Conduct root cause analysis (RCA) using Ishikawa diagram or 5-Why technique.
3. Implement CAPA and document in QA logs.

6. Abbreviations

• API: Active Pharmaceutical Ingredient
• RCA: Root Cause Analysis
• CAPA: Corrective and Preventive Action
• GMP: Good Manufacturing Practice

7. Documents

1. Cross-Contamination Monitoring Log – Annexure-1
2. Air Sampling Log – Annexure-2
3. Surface Swab Testing Record – Annexure-3
4. Cleaning Checklist – Annexure-4
5. Equipment Cleaning Record – Annexure-5

8. References

• WHO TRS 986 Annex 2: Cross-contamination in manufacturing
• EU GMP Chapter 5: Production
• Schedule M: Good Manufacturing Practices for Pharmaceuticals

9. SOP Version

Version: 2.0

10. Approval Section

11. Annexures

Annexure-1: Cross-Contamination Monitoring Log

Annexure-2: Air Sampling Log

Annexure-3: Surface Swab Testing Record

Annexure-4: Cleaning Checklist

Annexure-5: Equipment Cleaning Record

Revision History

Standard Operating Procedure for Ensuring Compliance with Cosmetic GMP Guidelines for Gels in Gel Manufacturing

1. Purpose

To establish standardized procedures for ensuring compliance with Cosmetic GMP (Good Manufacturing Practices) during the manufacturing of gel-based cosmetic products, in accordance with applicable regulatory standards such as ISO 22716.

2. Scope

This SOP applies to all activities related to the production, quality control, packaging, storage, and release of gel formulations categorized under cosmetic products.

3. Responsibilities

• Production Staff: Follow manufacturing procedures as per Cosmetic GMP standards.
• QA Department: Ensure that documentation, personnel hygiene, and premises meet GMP requirements.
• QC Department: Conduct quality tests on raw materials, in-process gels, and final products.

4. Accountability

The Head of Gel Manufacturing is accountable for overall GMP compliance and quality of cosmetic gel products.

5. Procedure

5.1 Premises and Hygiene

1. Ensure that premises are clean, well-maintained, and equipped with appropriate ventilation and lighting.
2. Implement daily and weekly cleaning schedules and maintain records.
3. Design workflows to minimize cross-contamination and human error.

5.2 Personnel Hygiene and Training

1. Mandate daily hygiene checks for all personnel entering production and QC areas.
2. Provide GMP training every 6 months and maintain attendance records.
3. Enforce use of PPE such as gloves, gowns, head covers, and face masks.

5.3 Equipment and Utilities

1. Clean and sanitize all equipment before and after each batch.
2. Calibrate weighing balances, pH meters, viscometers, and other equipment as per schedule.
3. Use filtered water systems validated for cosmetic manufacturing.

5.4 Raw Materials Management

1. Use only approved raw materials that meet pharmacopeial or cosmetic-grade specifications.
2. Segregate incoming raw materials into quarantine, approved, and rejected zones.
3. Label raw materials with batch numbers, expiry dates, and storage instructions.

5.5 Manufacturing Practices

1. Document each manufacturing step in a dedicated Batch Manufacturing Record (BMR).
2. Perform in-process checks for pH, viscosity, and appearance.
3. Avoid overheating thermolabile excipients during mixing.

5.6 Packaging and Labelling

1. Conduct line clearance before starting packaging activities.
2. Use tamper-evident packaging materials and ensure proper labeling.
3. Verify label compliance with cosmetic labeling regulations, including ingredients and batch numbers.

5.7 Quality Control and Product Release

1. Test each batch for microbial limits, heavy metals, and preservatives’ efficacy.
2. Retain reference samples and COA for every batch.
3. QA shall authorize release only after all specifications are met.

5.8 Documentation and Records

1. Maintain batch records, cleaning logs, calibration reports, and deviation logs for a minimum of 3 years.
2. Use controlled document formats with version control and approval signatures.

6. Abbreviations

• GMP: Good Manufacturing Practice
• QA: Quality Assurance
• QC: Quality Control
• PPE: Personal Protective Equipment
• BMR: Batch Manufacturing Record

7. Documents

1. Batch Manufacturing Record – Annexure-1
2. Personnel Hygiene Checklist – Annexure-2
3. Cleaning Log Sheet – Annexure-3
4. Calibration Log – Annexure-4
5. Raw Material Receipt Register – Annexure-5

8. References

• ISO 22716 – Guidelines on Good Manufacturing Practices for Cosmetic Products
• Schedule M – Cosmetics (India)
• US FDA Cosmetic GMP Guidelines

9. SOP Version

Version: 2.0

10. Approval Section

11. Annexures

Annexure-1: Batch Manufacturing Record

Annexure-2: Personnel Hygiene Checklist

Annexure-3: Cleaning Log Sheet

Annexure-4: Calibration Log

Annexure-5: Raw Material Receipt Register

Revision History

Standard Operating Procedure for Production of Thermosensitive Gels in Gel Manufacturing

1. Purpose

To define the procedure for manufacturing thermosensitive gel formulations, including material handling, solubilization, gelation temperature calibration, and quality control to ensure functional and regulatory compliance.

2. Scope

This SOP applies to all thermosensitive gel products manufactured in the Gel Manufacturing department of the pharmaceutical facility.

3. Responsibilities

• Production Officer: Execute batch manufacturing operations per batch manufacturing record (BMR).
• QC Analyst: Perform temperature calibration and viscosity measurements at different temperatures.
• QA Executive: Verify process adherence and record review for batch release.

4. Accountability

The Head of Gel Manufacturing shall be accountable for implementing and monitoring this SOP and ensuring compliance with GMP standards.

5. Procedure

5.1 Material Preparation

1. Receive and verify all excipients and APIs listed in the BMR.
2. Weigh materials in accordance with SOP for material dispensing in cleanroom conditions.

5.2 Solubilization and Mixing

1. Use cold or room-temperature purified water for initial dispersion of thermosensitive polymers (e.g., Poloxamers, Pluronics).
2. Mix under controlled low-shear conditions using a stainless steel stirrer or magnetic stirrer.
3. Incorporate other excipients such as preservatives, APIs, or enhancers as per formulation requirements.

5.3 Thermo-Gelling Behavior Calibration

1. Transfer small aliquots of the batch into sample vials.
2. Heat samples gradually from 10°C to 50°C and observe sol-gel transition point.
3. Document the gelation temperature range for the formulation.
4. Ensure the final formulation remains liquid at room temperature and gels at physiological temperature (~37°C).

5.4 Final Homogenization

1. Perform final homogenization using a high-shear mixer at 2000–3000 rpm for 10–15 minutes.
2. Maintain process temperature below the gelation point during mixing.

5.5 Filtration and Filling

1. Filter the gel using 0.45 µm or 0.22 µm membrane filter under laminar airflow.
2. Fill into appropriate primary packaging (e.g., collapsible tubes, bottles) using peristaltic or piston fillers at controlled temperature.

5.6 In-process and Final Testing

• Appearance, pH, viscosity at 25°C and 37°C, gelation temperature, microbial limits, and assay of API.

5.7 Documentation

• Complete all entries in BMR and attach analytical reports before batch release.

6. Abbreviations

• API: Active Pharmaceutical Ingredient
• BMR: Batch Manufacturing Record
• GMP: Good Manufacturing Practice
• QA: Quality Assurance
• QC: Quality Control

7. Documents

1. Batch Manufacturing Record – Annexure-1
2. Gelation Temperature Log – Annexure-2
3. Viscosity Test Report – Annexure-3
4. In-process Testing Checklist – Annexure-4

8. References

• ICH Q8(R2) – Pharmaceutical Development
• ICH Q9 – Quality Risk Management
• WHO TRS 961 – Annex 3: GMP Guidelines

9. SOP Version

Version: 2.0

10. Approval Section

11. Annexures

Annexure-1: Batch Manufacturing Record Template

Annexure-2: Gelation Temperature Log

Annexure-3: Viscosity Test Report

Annexure-4: In-process Testing Checklist

Revision History

Standard Operating Procedure for Cosmetic GMP Compliance in Gel Manufacturing

1. Purpose

This SOP defines the procedure to ensure that gel products classified as cosmetics are manufactured in compliance with Cosmetic Good Manufacturing Practice (GMP) guidelines as per Bureau of Indian Standards (IS 4707, IS 4011), ISO 22716, and other applicable regulatory frameworks.

2. Scope

This procedure applies to the manufacturing, quality control, packaging, and storage of gel-based cosmetic products within the Gel Manufacturing Department of the cosmetic product facility.

3. Responsibilities

• Production Supervisor: Ensures manufacturing practices adhere to GMP principles.
• QA Executive: Monitors documentation and performs in-process checks.
• Regulatory Affairs: Updates guidelines and verifies label compliance.
• Warehouse Officer: Ensures proper storage of raw materials and packaging components.

4. Accountability

The Head – Manufacturing shall ensure that all GMP requirements for cosmetic gels are implemented and maintained throughout the lifecycle of the product.

5. Procedure

5.1 Personnel Hygiene and Training

1. Ensure all personnel are trained in cosmetic GMP principles and hygiene requirements.
2. Personnel must wear clean uniforms, head covers, and gloves before entering the production area.
3. Document training records as per Annexure-1.

5.2 Raw Material Handling

1. Verify that all raw materials used in cosmetic gels are approved for cosmetic use and conform to BIS/ISO/INCI standards.
2. Label each material with the batch number, manufacturer details, and retest date.
3. Segregate raw materials used for cosmetics from those used for pharmaceuticals to avoid cross-contamination.

5.3 Manufacturing Environment

1. Maintain the environment as per ISO Class 8 or equivalent cleanliness standards.
2. Monitor temperature, humidity, and differential pressure daily.
3. Clean floors, walls, and ceilings daily using GMP-compliant cleaning agents.

5.4 Equipment Maintenance and Cleaning

1. Use only designated and dedicated equipment for cosmetic gel manufacturing.
2. Calibrate equipment at defined intervals and maintain records.
3. Clean all equipment before and after use following the validated cleaning procedure.

5.5 Batch Manufacturing Process

1. Follow approved manufacturing procedures specific to the gel product.
2. Record each step in the Batch Manufacturing Record (Annexure-2).
3. Ensure no deviation from the validated process unless change control is initiated.

5.6 Packaging and Labeling

1. Use only approved packaging material that complies with cosmetic regulatory standards.
2. Ensure that labeling includes ingredient list (INCI names), net content, manufacturer’s details, batch number, MRP, Mfg. and Expiry Date.
3. Verify printed materials as per SOP/QA/012/2025.

5.7 Storage and Distribution

1. Store cosmetic gels between 15–25°C with protection from light and moisture.
2. Use First-Expiry-First-Out (FEFO) system for inventory rotation.
3. Maintain distribution records including shipping conditions and customer details.

5.8 Quality Control and Stability

1. Test each batch for physical characteristics (color, clarity, consistency), pH, microbial contamination, and preservative efficacy.
2. Conduct real-time and accelerated stability studies per cosmetic guidelines.

6. Abbreviations

• GMP: Good Manufacturing Practice
• BMR: Batch Manufacturing Record
• BIS: Bureau of Indian Standards
• INCI: International Nomenclature Cosmetic Ingredient
• QA: Quality Assurance

7. Documents

1. Training Record – Annexure-1
2. Batch Manufacturing Record – Annexure-2
3. Equipment Cleaning Log – Annexure-3
4. Environmental Monitoring Sheet – Annexure-4
5. Packaging Component Verification Sheet – Annexure-5

8. References

• IS 4707: List of cosmetic raw materials generally not recognized as safe
• IS 4011: Methods of test for safety evaluation of cosmetics
• ISO 22716:2007 – Cosmetic Good Manufacturing Practices
• Drugs and Cosmetics Act and Rules (India)

9. SOP Version

Version: 2.0

10. Approval Section

11. Annexures

Annexure-1: Training Record

Annexure-2: Batch Manufacturing Record (BMR)

Includes formulation components, batch yield, in-process observations, deviations, and final product specifications.

Annexure-3: Equipment Cleaning Log

Document details of equipment cleaning, frequency, responsible personnel, and QA verification.

Annexure-4: Environmental Monitoring Sheet

Daily record of temperature, humidity, pressure differentials, and particulate matter in critical zones.

Annexure-5: Packaging Component Verification Sheet

Verification of label content, print quality, barcode accuracy, and material code against BOM.

Revision History